SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating SpringWorks Therapeutics, Inc. Buyout

Wilmington, Delaware--(Newsfile Corp. - April 28, 2025) - Rigrodsky Law, P.A. is investigating SpringWorks Therapeutics, Inc. ("SpringWorks") (NASDAQ: SWTX) regarding possible breaches of fiduciary duties and other violations of law related to SpringWorks' agreement to be acquired by Merck KGaA, Darmstadt, Germany. Under the terms of the agreement, SpringWorks shareholders will receive $47.00 per share in cash.

To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-springworks-therapeutics-inc.

To contact Seth D. Rigrodsky or Gina M. Serra cost free, call (302) 295-5310 or email [email protected].

Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising. Prior results do not guarantee a similar outcome.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/250055

You May Also Be Interested In

• Anthropic plans IPO potentially exceeding SpaceX's $86B record - Bloomberg
• EPA allows early switch to winter gasoline to lower prices
• Commercial National Financial Corporation (CEFC) Declares $0.15 Quarterly Dividend; 3.8% Yield